GPC1 and lung cancer: To test the ability of the Verita platform to capture and detect EV-associated cancer biomarkers directly from donor plasma, lung cancer and pancreatic cancer donor plasma was subjected to the ACE detection workflow, and chips were stained with antibodies for Program Death Ligand-1 (PD-L1) or Glypican 1 (GPC-1), respectively.